Journal of Animal Clinical Medicine
Online ISSN : 1881-1574
Print ISSN : 1344-6991
ISSN-L : 1344-6991
Short Report
Chemotherapy Trial Using Etoposide, Chlorambucil, and NSAIDs for Dogs with Splenic Hemangiosarcoma
Mitsuya YAMAMOTO
Author information
JOURNALS FREE ACCESS

2019 Volume 28 Issue 3 Pages 110-114

Details
Abstract

Oral low-dose chemotherapy using a combination of etoposide, Chlorambucil, filocoxib, and piroxicam was used to perform adjuvant chemotherapy on four dogs with grade 2 or 3 splenic hemangiosarcoma. The survival times of the four cases were 307, 248, 285, and 309 days, respectively. This study highlights an alternative adjuvant chemotherapeutic modality for canine splenic hemangiosarcoma. However, further investigations in a larger number of cases are desired.

Information related to the author
© 2019 Japanese Society of Clinical Veterinary Medicin
Previous article Next article
feedback
Top